旭輝控股集團(00884.HK)註銷3億份現有購股權
格隆匯5月30日丨旭輝控股集團(00884.HK)公告,2016年購股權計劃的目的在於激勵承授人在未來盡力爲集團作出貢獻及回報彼等過去的貢獻,監於股份的現行交易價格,公司董事會認爲現有購股權已無法達到上述目的。董事會謹此宣佈,經董事會批準及承授人同意,全部3億份現有購股權已根據2016年購股權計劃的條款自2025年5月30日起註銷。
於本公告日期,於註銷後,並無根據2016年購股權計劃已授出但尚未行使的購股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.